Neuroblastoma of the Urinary Bladder in an Infant

Abstract

As it originates from neural crest cells, Neuroblastoma (NBL) can arise anywhere along the sympathetic chain. However, its occurrence in the urinary bladder (UB) is extremely rare. We present a case of an incidentally diagnosed pelvic NBL arising from the dome of the UB in a 7-month-old infant. The mass was treated with surgical excision only after being classified as a very low risk group according to the International Neuroblastoma Risk Group staging system. The patient was disease free after 5 years of follow-up. Although rare, we suggest that NBL should be considered in the differential diagnosis of UB masses in children and investigated accordingly.

Keywords

neuroblastoma - pediatric oncology - urinary bladder - pediatric tumors

Note

Dr. Ahmed has Membership of Royal College of Surgeons (MRCS).

• References

• 1 Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 2010; 24 (01) 65-86
• 2 Janoueix-Lerosey I, Schleiermacher G, Delattre O. Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene 2010; 29 (11) 1566-1579
• 3 Shuangshoti S, Shuangshoti S, Nuchprayoon I. , et al. Natural course of low risk neuroblastoma. Pediatr Blood Cancer 2012; 58 (05) 690-694
• 4 Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007; 369 (9579): 2106-2120
• 5 Owens C, Irwin M. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 2012; 49 (03) 85-115
• 6 Kleihues P, Cavenee K. , eds. Neuroblastic tumours of adrenal gland and sympathetic nervous system. In: Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC, World Health Organization; 2000: 153
• 7 Kelly DR, Joshi VV. Neuroblastoma and related tumors. In: Parnham DM. , ed. Paediatric Neoplasia Morphology and Biology. Philadelphia, PA: Lippincott-Raven; 1996: 105-152
• 8 Ijiri R, Tanaka Y, Kou K, Nishihira H, Nishi T. Bladder origin neuroblastoma detected by mass screening. Urology 1998; 52 (06) 1139-1141
• 9 Yokoyama S, Hirakawa H, Ueno S, Yabe H, Hiraoka N. Neuroblastoma of the urinary bladder, preclinically detected by mass screening. Pediatrics 1999; 103 (05) e67
• 10 Knoedler CJ, Kay R, Knoedler Sr JP, Wiig TH. Pelvic neuroblastoma. J Urol 1989; 141 (04) 905-907
• 11 Sáez C, Márquez C, Quiroga E. , et al. Neuroblastoma of the urinary bladder in an infant clinically detected by hematuria. Med Pediatr Oncol 2000; 35 (05) 488-492
• 12 Kojima S, Yagi M, Asagiri K. , et al. Infantile neuroblastoma of the urinary bladder detected by hematuria. Pediatr Surg Int 2013; 29 (07) 753-757
• 13 Zhu J, Hoag NA, Gustafson P, Afshar K, Macneily AE. Pediatric bladder neuroblastoma: case report and literature review. Can Urol Assoc J 2013; 7 (9-10): E609-E611
• 14 Hartman C, Williamson AK, Friedman AA, Palmer LS, Fine RG. Bladder ganglioneuroma in a 5-year-old girl presenting with a urinary tract infection and hematuria: case report and review of the literature. Urology 2015; 85 (02) 467-469
• 15 Cohn SL, Pearson AD, London WB. , et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol 2009; 27 (02) 289-297
• 16 Shimada H, Ambros IM, Dehner LP. , et al. The International neuroblastoma pathology classification (the Shimada system). Cancer 1999; 86 (02) 364-372
• 17 Brodeur GM, Pritchard J, Berthold F. , et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11 (08) 1466-1477
• 18 Everson TC, Cole WH. Spontaneous regression of malignant disease. J Am Med Assoc 1959; 169 (15) 1758-1759
• 19 Ghazali S. Pelvic neuroblastoma: a better prognosis. Ann Surg 1974; 179 (01) 115-118
• 20 Yamamoto K, Hanada R, Kikuchi A. , et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998; 16 (04) 1265-1269
• 21 Hero B, Simon T, Spitz R. , et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 2008; 26 (09) 1504-1510